Basilea Pharmaceutica AG
Stock Forecast, Prediction & Price Target
Basilea Pharmaceutica AG Financial Estimates
Basilea Pharmaceutica AG Revenue Estimates
Basilea Pharmaceutica AG EBITDA Estimates
Basilea Pharmaceutica AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF148.12M N/A | CHF147.76M -0.24% | CHF157.63M 6.67% | Avg: CHF197.86M Low: CHF167.82M High: CHF271.46M avg. 25.52% | Avg: CHF223.12M Low: CHF198.39M High: CHF290.54M avg. 12.76% | Avg: CHF223.31M Low: CHF198.55M High: CHF290.78M avg. 0.08% | Avg: CHF204.34M Low: CHF181.69M High: CHF266.09M avg. -8.49% |
Net Income
% change YoY
| CHF-6.83M N/A | CHF12.14M 277.82% | CHF10.45M -13.96% | Avg: CHF29.03M Low: CHF4.73M High: CHF48.35M avg. 177.80% | Avg: CHF64.47M Low: CHF42.86M High: CHF87.91M avg. 122.08% | Avg: CHF73.04M Low: CHF62.51M High: CHF101.72M avg. 13.27% | Avg: CHF79.65M Low: CHF68.17M High: CHF110.94M avg. 9.06% |
EBITDA
% change YoY
| CHF3.62M N/A | CHF19.44M 436.12% | CHF23.18M 19.26% | Avg: CHF785.58K Low: CHF666.32K High: CHF1.07M avg. -96.61% | Avg: CHF885.90K Low: CHF787.69K High: CHF1.15M avg. 12.76% | Avg: CHF886.64K Low: CHF788.35K High: CHF1.15M avg. 0.08% | Avg: CHF811.34K Low: CHF721.39K High: CHF1.05M avg. -8.49% |
EPS
% change YoY
| -$0.58 N/A | $1.02 275.86% | $0.87 -14.70% | Avg: $2.33 Low: $0.39 High: $3.98 avg. 167.45% | Avg: $5.14 Low: $3.53 High: $7.24 avg. 120.75% | Avg: $6.02 Low: $5.15 High: $8.38 avg. 17.10% | Avg: $6.56 Low: $5.61 High: $9.14 avg. 9.06% |
Operating Expenses
% change YoY
| CHF122.87M N/A | CHF104.61M -14.85% | CHF111.63M 6.70% | Avg: CHF42.64M Low: CHF36.17M High: CHF58.50M avg. -61.79% | Avg: CHF48.09M Low: CHF42.75M High: CHF62.62M avg. 12.76% | Avg: CHF48.13M Low: CHF42.79M High: CHF62.67M avg. 0.08% | Avg: CHF44.04M Low: CHF39.16M High: CHF57.35M avg. -8.49% |
FAQ
What is Basilea Pharmaceutica AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 80.55% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is 4.73M, average is 29.03M and high is 48.35M.
What is Basilea Pharmaceutica AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 7.47% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is CHF167.82M, average is CHF197.86M and high is CHF271.46M.
What is Basilea Pharmaceutica AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 78.59% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is $0.39, average is $2.33 and high is CHF3.98.